Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene

C I Bargmann1, R A Weinberg

  • 1Whitehead Institute for Biomedical Research, Nine Cambridge Center, MA 02142.

Insights

A single mutation in the rat neu gene

Area of Science:

  • Oncogenesis
  • Molecular Biology
  • Signal Transduction

Background:

  • The rat neu gene encodes the receptor-like p185 protein.
  • A specific mutation in the transmembrane domain can convert the normal neu gene into a potent oncogene.
  • Understanding the biochemical changes associated with this oncogenic transformation is crucial.

Purpose of the Study:

  • To investigate the biochemical consequences of the oncogenic mutation in the p185 protein.
  • To compare the phosphorylation status of normal and transforming p185 molecules.
  • To determine if the transforming p185 protein possesses intrinsic kinase activity.

Main Methods:

  • Studying protein phosphorylation in membrane preparations.
  • In vitro biochemical assays to assess kinase activity.
  • Comparing phosphorylation levels between normal and mutated p185 proteins.

Main Results:

  • The transforming p185 protein exhibits significantly higher in vitro phosphorylation compared to the normal p185.
  • This enhanced phosphorylation occurs on tyrosine residues and requires functional p185 kinase activity.
  • Normal p185 does not show increased phosphorylation even in the presence of the transforming p185 within the same cell.

Conclusions:

  • The transforming p185 protein is intrinsically associated with active tyrosine kinase activity.
  • This active kinase function is directly linked to the mutation in the transmembrane domain.
  • The transmembrane domain of p185 plays a critical role in regulating its kinase activity and oncogenic potential.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...